AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...
Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...
The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...
The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...
Axoltis’ drug, NX210c, failed to meet clinical endpoints in a Phase II trial – but the company says other readouts are ...
IgniteData and RealTime eClinical Solutions partner to let RealTime's clinical research sites use IgniteData's Archer ...
UK-based OMass Therapeutics has closed an oversubscribed $310 million Series C round to drive its endocrinology and ...
Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...
Susanne Michel, vice president, head of HTA methods and evidence planning at Clinigen, and Michael Epstein, vice president, ...
Study finds Bluesky and X users share clinical trial information differently, which could impact recruitment strategies ...
Prader-Willi syndrome is a rare genetic condition that can present from birth. Its occurrence is around 1 in 15,000, and tens ...
The legal experts recently discussed the mechanics of direct-to-patient (DTP) and direct-to-employer (DTE) models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results